Enfusion Results Presentation Deck

*:enfusion ASSETS Current Assets: Cash and cash equivalents Accounts receivable, net Prepaid expenses Other current assets Total current assets Property and equipment, net Right-of-use-assets, net Other assets Total assets ENFUSION, INC. CONSOLIDATED BALANCE SHEETS (dollars in thousands, except shares and unit amounts and par value) LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable Accrued expenses and other current liabilities Current portion of lease liabilities Total current liabilities Lease liabilities, net of current portion Total liabilities Stockholders' Equity: Class A common stock, $0.001 par value; 1,000,000,000 shares authorized, 74,081,623 and 70,859,711 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively Class B common stock, $0.001 par value; 150,000,000 shares authorized, 41,198,767 and 43,198,767 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively Additional paid-in capital Accumulated deficit Accumulated other comprehensive loss Total stockholders' equity attributable to Enfusion, Inc. Non-controlling interests Total stockholders' equity Total liabilities and stockholders' equity $ $ $ S As of March 31, 2023 (Unaudited) 54,598 24,356 5,600 2,093 86,647 16,879 13,438 4,529 121,493 1,290 7,403 5,013 13,706 8,642 22,348 74 41 240,075 (176,012) (473) 63,705 35,440 99,145 121,493 As of December 31, 2022 $ $ $ $ 62,545 25,855 6,105 2,303 96,808 15,759 6,732 4,484 123,783 1,685 11,665 4,030 17,380 2,959 20,339 71 43 244,260 (178,863) (504) 65,007 38,437 103,444 123,783 Ⓒ2023 ENFUSION. ALL RIGHTS RESERVED. 14

View entire presentation